ATH434-DP2 clinical trials

Open-Label Extension Study to Provide Access to ATH434 in Patients with Multiple System Atrophy

This study is looking at a new medicine called ATH434 for people with Multiple System Atrophy (MSA). It's checking if the medicine is safe and if people can take it for a long time. Researchers will observe side effects and monitor general health.